Global Kinetics Kicks Off US Parkinson's Outcomes Trial For Wearable Monitor

The Australian company Global Kinetics has developed the Personal KinetiGraph, which includes a wearable smartwatch and a cloud-based system for continuous monitoring of Parkinson's disease symptoms to help improve patient management. KinetiGraph is 510(k)-cleared and CE marked, but the APPRISE multi-center trial will test the system’s ability to improve outcomes. The company hopes to convince US payers to cover it.

Global Kinetics Parkinson’s KinetiGraph
Global Kinetics' KinetiGraph • Source: Global Kinetics Corp.

More from Clinical Trials

More from R&D